Mirae Asset Global Etfs Holdings Ltd. Iovance Biotherapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 178,303 shares of IOVA stock, worth $722,127. This represents 0.0% of its overall portfolio holdings.
Number of Shares
178,303
Previous 164,316
8.51%
Holding current value
$722,127
Previous $1.54 Million
14.46%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IOVA
# of Institutions
343Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$112 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$98.9 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$89.6 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$86 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$49.6 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $639M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...